TDGF1
Reactivity: Human
ELISA
Host: Rabbit
Polyclonal
HRP
Application Notes
Flow Cytometry (1:100) Immunocytochemistry (1:50-1:200) Immunofluorescence (1:50-1:200) The optimal working dilution should be determined by the end user.
Restrictions
For Research Use only
Format
Liquid
Buffer
In Tris-glycine, 150 mM NaCl
Storage
4 °C
Storage Comment
Store at 4°C. Do not freeze.
Xing, Hu, Pietersz, Hosick, McKenzie: "Cripto: a novel target for antibody-based cancer immunotherapy." in: Cancer research, Vol. 64, Issue 11, pp. 4018-23, (2004) (PubMed).
Adamson, Minchiotti, Salomon: "Cripto: a tumor growth factor and more." in: Journal of cellular physiology, Vol. 190, Issue 3, pp. 267-78, (2002) (PubMed).
Schiffer, Foley, Kaffashan, Hronowski, Zichittella, Yeo, Miatkowski, Adkins, Damon, Whitman, Salomon, Sanicola, Williams: "Fucosylation of Cripto is required for its ability to facilitate nodal signaling." in: The Journal of biological chemistry, Vol. 276, Issue 41, pp. 37769-78, (2001) (PubMed).